Contact Us
Fertility Drugs Global Market Report 2025
Global Fertility Drugs Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Fertility Drugs Global Market Report 2025

 By Type Of Drug (Prescription Fertility Drugs, Over-The-Counter Fertility drugs, By Route of Administration (Oral, Intravenous, Subcutaneous, Intramuscular), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Fertility Drugs Market?

Fertility drugs refer to a term used to describe medications that cause your body to release hormones that regulate or prompt ovulation, or the release of an egg from your ovary.

The main types of fertility drugs are prescription fertility drugs and over-the-counter fertility drugs. The drugs are administered orally, intravenously, subcutaneously, and intramuscularly to male and female patients. Subcutaneous administration refers to the process of injecting the drugs into the fatty tissue just beneath the skin. The drugs are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

Fertility Drugs Market 2025 - 2034

What Is The Fertility Drugs Market Size 2025 And Growth Rate?

The fertility drugs market size has grown strongly in recent years. It will grow from $3.13 billion in 2024 to $3.36 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increasing infertility rates, advances in reproductive medicine, assisted reproductive technologies (ART), and delayed childbearing.

What Is The Fertility Drugs Market Growth Forecast?

The fertility drugs market size is expected to see strong growth in the next few years. It will grow to $4.39 billion in 2029 at a compound annual growth rate (CAGR) of 6.9% . The growth in the forecast period can be attributed to the aging population, lifestyle factors, assisted reproductive technologies (art), and personalized medicine. Major trends in the forecast period include advancements in assisted reproductive technologies (ART), ovulation-inducing medications, and hormone therapy.

Customer representative image Book your 30 minutes free consultation with our research experts

How Is The Fertility Drugs Market Segmented?

The fertility drugs market covered in this report is segmented –

1) By Type Of Drug: Prescription Fertility Drugs, Over-The-Counter Fertility drugs

2) By Route of Administration: Oral, Intravenous, Subcutaneous, Intramuscular

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Prescription Fertility Drugs: Gonadotropins, Clomiphene Citrate, Letrozole, GnRH Agonists, GnRH Antagonists, Progesterone

2) By Over-The-Counter Fertility Drugs: Ovulation Predictor Kits, Fertility Supplements, Fertility Monitors

What Is Driving The Fertility Drugs Market? Global Increase In Infertility Rates Fuels Growth Of Fertility Drug Market

The growth of the market for fertility drugs is driven by the increasing rates of infertility across the globe. Infertility is the inability to conceive after trying for 12 consecutive months. Fertility drugs are widely used to treat infertility in both men and women. The rising rates of infertility are attributed to physiological problems, hormone problems, and lifestyle or environmental factors. To treat infertility problems in women, fertility drugs are used to regulate their ovulation cycles, which affects the sale of these drugs. For instance, in February 2024, according to Office for National Statistics, a UK based executive office of the UK Statistics Authority, the total fertility rate (TFR) decreased to 1.49 children per woman in 2022 from 1.55 in 2021. Therefore, the rising cases of infertility across the globe are increasing the demand for fertility drugs, resulting in the fertility drug market growth.

What Is Driving The Fertility Drugs Market? Rising Prevalence Of Obesity To Drive Market Growth

The increasing prevalence of obesity is expected to propel the growth of the fertility drugs market going forward. Obesity is a medical condition characterized by an excessive accumulation of body fat to the extent that it may have adverse effects on an individual's health. Obesity is a known contributor to infertility in both men and women. This increased demand is driven by the need for specialized treatments, greater awareness, supportive government policies, and ongoing research and development efforts tailored to addressing fertility challenges associated with obesity. For instance, in March 2023, according to the World Heart Federation, a Switzerland-based non-government global cardiovascular community, around 2.3 billion adults and children were obese or overweight globally, and with the current obesity trend, it is estimated that the number of people living with obesity will reach 2.7 billion by 2025. Therefore, the increasing prevalence of obesity is driving the growth of the fertility drugs market.

Who Are The Major Players In The Global Fertility Drugs Market?

Major companies operating in the fertility drugs market include Merck & Co., Ferring Pharmaceuticals Inc., Bayer AG, Berlex Laboratories Inc., Janssen Pharmaceutical Inc., Pfizer Inc., Novartis AG, Procter & Gamble Health Limited, Zydus Lifesciences Limited, Livzon Pharmaceutical Group Inc., Abbott Laboratories, Sanofi S.A., Eli Lilly and Company, Serono Inc., Novagen Healthcare Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Schering-Plough Corporation, Regeneron Pharmaceuticals Inc., F. Hoffmann-La Roche AG, Vitrolife, Cook Medical, Organon Group, The Cooper Companies Inc., Irvine Scientific, Genea Biomedx, Mankind Pharma

What Are The Key Trends Of The Global Fertility Drugs Market? Enhancing Fertility Treatments with Single-Dose Prefilled Syringes

Major companies operating in the fertility drugs market are focusing on developing innovative solutions, including peptide-based injectable treatments, to enhance reproductive health outcomes. Peptide-based injectable treatments refer to medications that utilize synthetic or naturally occurring peptides to stimulate or regulate hormonal activity, particularly in the context of fertility and reproductive health. For instance, in February 2024, Lupin Limited, an India-based pharmaceutical company, launched a ganirelix acetate injection in the United States. This medication is commonly used as a part of assisted reproductive technology (ART) protocols to prevent premature ovulation during controlled ovarian stimulation in women undergoing in vitro fertilization (IVF). Ganirelix acetate is a GnRH antagonist that helps regulate hormone levels, allowing for better control of the ovarian stimulation process. The US launch reflects Lupin's ongoing commitment to expanding its product offerings in the reproductive health sector, as well as its focus on addressing the needs of patients undergoing fertility treatments.

What Are The Key Trends Of The Global Fertility Drugs Market? Increasing Awareness And Education Initiatives In The Fertility Drugs Market

Major companies operating in the drugs fertility market are launching new campaigns for fertility care to secure a competitive lead in the market. Fertility care campaigns refer to organized initiatives, often conducted by governments, healthcare organizations, or advocacy groups, to raise awareness and provide education on issues related to fertility, infertility, reproductive health, and the available treatments and care options. For instance, in August 2022, Pinnacle Fertility, Inc., a US-based fertility care company launched the Save IVF campaign, which focuses on raising awareness about potential new legislation that could adversely affect family-building treatments like IVF in the absence of federal protection from Roe V. Wade. With the changing legal landscape, the campaign emphasizes the importance of preserving access to fertility care and encourages individuals to join the cause by taking the #SaveIVF Pledge. The campaign highlights the far-reaching impact these bills can have on the ability to start families and urges proactive steps to protect fertility care. Pinnacle Fertility aims to educate and mobilize its community and the public to safeguard the rights of those in need of fertility treatments and to combat legislative threats that could limit access.

Need data on a specific region in this market?

Fertility Drugs Market Merger And Acquisition: Sumitovant Biopharma’s Acquisition Strengthens Myovant’s Women’s Health Treatment Portfolio

In March 2023, Sumitovant Biopharma Ltd., a US-based biopharmaceutical company acquired Myovant Sciences Ltd. for an undisclosed amount. The acquisition of Myovant by Sumitovant enhances their collaborative capabilities, resources, and expertise, allowing them to address unmet needs in women's health and prostate cancer, advance the development of their combined pipeline, and expand the impact of their differentiated therapies for the benefit of patient communities. Myovant Sciences Ltd. is a US-based biotechnology company that specializes in the development and commercialization of new treatments for women's diseases and endocrine disorders, with a focus on addressing conditions such as heavy menstrual bleeding associated with uterine fibroids and female infertility.

Regional Outlook For The Global Fertility Drugs Market

North America was the largest region in the fertility drugs market in 2024. The Middle East is expected to be the fastest-growing region in the drugs for infertility market during the forecast period. The regions covered in the fertility drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the fertility drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

What Defines the Fertility Drugs Market?

The fertility drugs market consists of sales of clomiphene citrate, gonadotropins, and metformin. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Fertility Drugs Industry?

The fertility drugs market research report is one of a series of new reports from The Business Research Company that provides fertility drugs market statistics, including fertility drugs industry global market size, regional shares, competitors with a fertility drugs market share, detailed fertility drugs market segments, market trends and opportunities, and any further data you may need to thrive in the fertility drugs industry. This fertility drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Fertility Drugs Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $3.36 billion
Revenue Forecast In 2034 $4.39 billion
Growth Rate CAGR of 6.9% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type Of Drug: Prescription Fertility Drugs, Over-The-Counter Fertility drugs
2) By Route of Administration: Oral, Intravenous, Subcutaneous, Intramuscular
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Prescription Fertility Drugs: Gonadotropins, Clomiphene Citrate, Letrozole, GnRH Agonists, GnRH Antagonists, Progesterone
2) By Over-The-Counter Fertility Drugs: Ovulation Predictor Kits, Fertility Supplements, Fertility Monitors
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Merck & Co., Ferring Pharmaceuticals Inc., Bayer AG, Berlex Laboratories Inc., Janssen Pharmaceutical Inc., Pfizer Inc., Novartis AG, Procter & Gamble Health Limited, Zydus Lifesciences Limited, Livzon Pharmaceutical Group Inc., Abbott Laboratories, Sanofi S.A., Eli Lilly and Company, Serono Inc., Novagen Healthcare Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Schering-Plough Corporation, Regeneron Pharmaceuticals Inc., F. Hoffmann-La Roche AG, Vitrolife, Cook Medical, Organon Group, The Cooper Companies Inc., Irvine Scientific, Genea Biomedx, Mankind Pharma
Customization Scope Request for Sample
Pricing And Purchase Options Explore Purchase Options
Market Size Value In 2025 $3.36 billion
Revenue Forecast In 2034 $4.39 billion
Growth Rate CAGR of 6.9% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type Of Drug: Prescription Fertility Drugs, Over-The-Counter Fertility drugs
2) By Route of Administration: Oral, Intravenous, Subcutaneous, Intramuscular
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Prescription Fertility Drugs: Gonadotropins, Clomiphene Citrate, Letrozole, GnRH Agonists, GnRH Antagonists, Progesterone
2) By Over-The-Counter Fertility Drugs: Ovulation Predictor Kits, Fertility Supplements, Fertility Monitors
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Merck & Co., Ferring Pharmaceuticals Inc., Bayer AG, Berlex Laboratories Inc., Janssen Pharmaceutical Inc., Pfizer Inc., Novartis AG, Procter & Gamble Health Limited, Zydus Lifesciences Limited, Livzon Pharmaceutical Group Inc., Abbott Laboratories, Sanofi S.A., Eli Lilly and Company, Serono Inc., Novagen Healthcare Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Schering-Plough Corporation, Regeneron Pharmaceuticals Inc., F. Hoffmann-La Roche AG, Vitrolife, Cook Medical, Organon Group, The Cooper Companies Inc., Irvine Scientific, Genea Biomedx, Mankind Pharma
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Fertility Drugs Market Characteristics

3. Fertility Drugs Market Trends And Strategies

4. Fertility Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Fertility Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Fertility Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Fertility Drugs Market Growth Rate Analysis

5.4. Global Fertility Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Fertility Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Fertility Drugs Total Addressable Market (TAM)

6. Fertility Drugs Market Segmentation

6.1. Global Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Prescription Fertility Drugs

Over-The-Counter Fertility Drugs

6.2. Global Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Intravenous

Subcutaneous

Intramuscular

6.3. Global Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

6.4. Global Fertility Drugs Market, Sub-Segmentation Of Prescription Fertility Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gonadotropins

Clomiphene Citrate

Letrozole

GnRH Agonists

GnRH Antagonists

Progesterone

6.5. Global Fertility Drugs Market, Sub-Segmentation Of Over-The-Counter Fertility Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Ovulation Predictor Kits

Fertility Supplements

Fertility Monitors

7. Fertility Drugs Market Regional And Country Analysis

7.1. Global Fertility Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Fertility Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Fertility Drugs Market

8.1. Asia-Pacific Fertility Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Fertility Drugs Market

9.1. China Fertility Drugs Market Overview

9.2. China Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Fertility Drugs Market

10.1. India Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Fertility Drugs Market

11.1. Japan Fertility Drugs Market Overview

11.2. Japan Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Fertility Drugs Market

12.1. Australia Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Fertility Drugs Market

13.1. Indonesia Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Fertility Drugs Market

14.1. South Korea Fertility Drugs Market Overview

14.2. South Korea Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Fertility Drugs Market

15.1. Western Europe Fertility Drugs Market Overview

15.2. Western Europe Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Fertility Drugs Market

16.1. UK Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Fertility Drugs Market

17.1. Germany Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Fertility Drugs Market

18.1. France Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Fertility Drugs Market

19.1. Italy Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Fertility Drugs Market

20.1. Spain Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Fertility Drugs Market

21.1. Eastern Europe Fertility Drugs Market Overview

21.2. Eastern Europe Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Fertility Drugs Market

22.1. Russia Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Fertility Drugs Market

23.1. North America Fertility Drugs Market Overview

23.2. North America Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Fertility Drugs Market

24.1. USA Fertility Drugs Market Overview

24.2. USA Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Fertility Drugs Market

25.1. Canada Fertility Drugs Market Overview

25.2. Canada Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Fertility Drugs Market

26.1. South America Fertility Drugs Market Overview

26.2. South America Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Fertility Drugs Market

27.1. Brazil Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Fertility Drugs Market

28.1. Middle East Fertility Drugs Market Overview

28.2. Middle East Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Fertility Drugs Market

29.1. Africa Fertility Drugs Market Overview

29.2. Africa Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Fertility Drugs Market Competitive Landscape And Company Profiles

30.1. Fertility Drugs Market Competitive Landscape

30.2. Fertility Drugs Market Company Profiles

30.2.1. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Ferring Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Berlex Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Janssen Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Fertility Drugs Market Other Major And Innovative Companies

31.1. Pfizer Inc.

31.2. Novartis AG

31.3. Procter & Gamble Health Limited

31.4. Zydus Lifesciences Limited

31.5. Livzon Pharmaceutical Group Inc.

31.6. Abbott Laboratories

31.7. Sanofi S.A.

31.8. Eli Lilly and Company

31.9. Serono Inc.

31.10. Novagen Healthcare Pvt. Ltd.

31.11. Takeda Pharmaceutical Co. Ltd.

31.12. AstraZeneca plc

31.13. Aurobindo Pharma Ltd.

31.14. Schering-Plough Corporation

31.15. Regeneron Pharmaceuticals Inc.

32. Global Fertility Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Fertility Drugs Market

34. Recent Developments In The Fertility Drugs Market

35. Fertility Drugs Market High Potential Countries, Segments and Strategies

35.1 Fertility Drugs Market In 2029 - Countries Offering Most New Opportunities

35.2 Fertility Drugs Market In 2029 - Segments Offering Most New Opportunities

35.3 Fertility Drugs Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Fertility Drugs Market, Sub-Segmentation Of Prescription Fertility Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Fertility Drugs Market, Sub-Segmentation Of Over-The-Counter Fertility Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Fertility Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Fertility Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: China, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: India, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Indonesia, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: South Korea, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Western Europe, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: UK, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Germany, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: France, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Italy, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Spain, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Eastern Europe, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Russia, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: North America, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: USA, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Canada, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: South America, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Brazil, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Middle East, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Africa, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Merck & Co. Financial Performance
  • Table 77: Ferring Pharmaceuticals Inc. Financial Performance
  • Table 78: Bayer AG Financial Performance
  • Table 79: Berlex Laboratories Inc. Financial Performance
  • Table 80: Janssen Pharmaceutical Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Fertility Drugs Market, Sub-Segmentation Of Prescription Fertility Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Fertility Drugs Market, Sub-Segmentation Of Over-The-Counter Fertility Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Fertility Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Fertility Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: China, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: India, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Indonesia, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: South Korea, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Western Europe, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: UK, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Germany, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: France, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Italy, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Spain, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Eastern Europe, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Russia, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: North America, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: USA, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Canada, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: South America, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Brazil, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Middle East, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Africa, Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Merck & Co. Financial Performance
  • Figure 77: Ferring Pharmaceuticals Inc. Financial Performance
  • Figure 78: Bayer AG Financial Performance
  • Figure 79: Berlex Laboratories Inc. Financial Performance
  • Figure 80: Janssen Pharmaceutical Inc. Financial Performance

Frequently Asked Questions

Fertility drugs refer to a term used to describe medications that cause your body to release hormones that regulate or prompt ovulation, or the release of an egg from your ovary. For further insights on the Fertility Drugs market, request a sample here

The Fertility Drugs market major growth driver - Rising Prevalence Of Obesity To Drive Market Growth. For further insights on the Fertility Drugs market, request a sample here

The Fertility Drugs market size has grown strongly in recent years. The fertility drugs market size has grown strongly in recent years. It will grow from $3.13 billion in 2024 to $3.36 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increasing infertility rates, advances in reproductive medicine, assisted reproductive technologies (ART), and delayed childbearing. The fertility drugs market size is expected to see strong growth in the next few years. It will grow to $4.39 billion in 2029 at a compound annual growth rate (CAGR) of 6.9% . The growth in the forecast period can be attributed to the aging population, lifestyle factors, assisted reproductive technologies (art), and personalized medicine. Major trends in the forecast period include advancements in assisted reproductive technologies (ART), ovulation-inducing medications, and hormone therapy. For further insights on the Fertility Drugs market, request a sample here

The fertility drugs market covered in this report is segmented –
1) By Type Of Drug: Prescription Fertility Drugs, Over-The-Counter Fertility drugs
2) By Route of Administration: Oral, Intravenous, Subcutaneous, Intramuscular
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Prescription Fertility Drugs: Gonadotropins, Clomiphene Citrate, Letrozole, GnRH Agonists, GnRH Antagonists, Progesterone
2) By Over-The-Counter Fertility Drugs: Ovulation Predictor Kits, Fertility Supplements, Fertility Monitors For further insights on the Fertility Drugs market,
request a sample here

North America was the largest region in the fertility drugs market in 2024. The Middle East is expected to be the fastest-growing region in the drugs for infertility market during the forecast period. The regions covered in the fertility drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the Fertility Drugs market, request a sample here.

Major companies operating in the fertility drugs market include Merck & Co., Ferring Pharmaceuticals Inc., Bayer AG, Berlex Laboratories Inc., Janssen Pharmaceutical Inc., Pfizer Inc., Novartis AG, Procter & Gamble Health Limited, Zydus Lifesciences Limited, Livzon Pharmaceutical Group Inc., Abbott Laboratories, Sanofi S.A., Eli Lilly and Company, Serono Inc., Novagen Healthcare Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Schering-Plough Corporation, Regeneron Pharmaceuticals Inc., F. Hoffmann-La Roche AG, Vitrolife, Cook Medical, Organon Group, The Cooper Companies Inc., Irvine Scientific, Genea Biomedx, Mankind Pharma . For further insights on the Fertility Drugs market, request a sample here.

Major trends in the Fertility Drugs market include Increasing Awareness And Education Initiatives In The Fertility Drugs Market. For further insights on the Fertility Drugs market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top